Intensity-modulated radiation therapy (IMRT) for nasopharyngeal cancer (NPC) allowed a better distribution of the dose to the tumor volume, sparing surrounding structures. Aim of the study is the objective evaluation of olfactory and gustatory impairments in patients who underwent chemo-radiotherapy for NPC. Correlation between smell and taste alterations, xerostomy, and radiation technique was investigated. Thirty healthy subjects and 30 patients treated with chemoradiation therapy for NPC, with at least a 2-years follow-up period, were evaluated. All subjects underwent symptoms evaluation, endoscopic fiber optic nasal examination, taste strips, Sniffin' sticks tests, Radiation Therapy Oncology Group/European Organisation for Research and Treatment of Cancer late radiation morbidity scoring system. Patients were divided in 2 groups: 2-dimensional radiotherapy/conformal 3-dimensional radiotherapy and IMRT. A higher percentage of rhinorrhea, nasal obstruction, xerostomy, hyposmia, hypogeusia, mucosal hyperemia, and presence of nasopharyngeal secretions was found in irradiated subjects (P < 0.05). Concerning olfactory and gustatory scores, we demonstrated a statistically significant difference between healthy subjects and irradiated patients (P < 0.05), with lower gustatory total score in IMRT group (P < 0.01). In conclusion, chemo-radiotherapy for NPC induces long-term smell and taste impairments, which can compromise quality of life. Although based on small samples, it is also important to consider that IMRT can induce higher taste dysfunction compared with traditional techniques.
Introduction
Nasopharyngeal carcinoma (NPC) represents a rare tumor in Europe and United States, whereas its incidence is higher in Eastern countries, such as China and Taiwan. Official surveys of International Agency for Research on Cancer estimated that the incidence of NPC in China in 2002 was 22.2 men and 9.8 women/100 000 inhabitants; in Europe the incidence was 0.3-0.4 men and 0.1-0.2 women/100 000 inhabitants (Parkin et al. 2002; Ma and Cao 2010) .
Radiation therapy (RT) is the main treatment of NPC in early and late stages; its efficacy can be improved by the association with concurrent or adjuvant chemotherapy schemes (Airoldi et al. 2009 ). Late toxicities due to these treatments, such as xerostomy, auditory impairment, and tissue fibrosis, are not uncommon (Takimoto et al. 1991; Lee et al. 1992; Chaudhry and Akhtar 1995; Stern et al. 1995) .
Innovations in radiotherapy techniques, as intensity-modulated radiation therapy (IMRT), allowed a better distribution of the dose to the tumor volume, sparing surrounding structures with a lesser incidence of side effects, compared with traditional 2-dimensional and conformal 3-dimensional techniques.
Irradiation fields involve nasal and oral mucous membranes determining acute and late adverse effects. Moreover, as the tumor's location is in close proximity to the central nervous system, some of the brain structures are in the track of the radiation beams when the patients receive radiation treatment (Di Lorenzo et al. 1978; Glass et al. 1984) .
Among the radiation side effects, there is smell and taste impairment, which may interfere with alimentation and subject's relationship with environment. Disorders in olfactory function may be conductive or sensorineural. Conductive smelling problems are due to mechanical obstruction of airflow to the upper nasal cavity , whereas sensorineural disorders are due to defects in the receptors, olfactory nerve fibers, or central structures.
The abilities to detect an odor above a certain threshold, to discriminate between different smells, and to identify a particular odor are essential for normal olfactory activity; they depend by the integrity of all the structures involved in smell function, from olfactory mucosa to central nervous ways.
Similarly to smell, taste alterations can be related to oral mucosa pathologies or to nervous disorders. Hypogeusia is a common complaint in patients undergone radiation and/or chemotherapy for head and neck malignancies. Different alterations for specific tastes are reported in literature (Mossman and Henkin 1978; Mossman et al. 1982; Maes et al. 2002) .
Late toxicities may impact on patients' quality of life; therefore, their accurate evaluation is important for an adequate management of long survivors.
Aim of this retrospective observational study is the objective evaluation of sensorial impairments, by the means of Sniffin' sticks and taste strips tests, in patients treated with chemo-RT for NPC. Furthermore correlation between smell and taste alterations, other late toxicities, such as xerostomy, and radiation technique was investigated.
Materials and methods
In this retrospective observational study, 30 healthy subjects and 30 patients treated with chemo-RT for NPC between 2003 and 2011 at 1st ENT Division, Surgical Sciences Department, and Radiation Oncology Unit, Department of Oncology, University of Turin, were enrolled. Each patient underwent neoadjuvant and/or concomitant chemotherapy associated to radiotherapy. All patients included in the study were disease free at the time of engagement. Exclusion criteria were chemotherapy or radiotherapy for second tumors or relapses, neurological diseases (i.e. degenerative and vascular diseases), use of drugs or occupational exposure to substances, which could determinate gustatory and/or olfactory alterations. Enrolled patients had at least a 2-years follow-up period (mean 59 months, range 24-124 months) in order to evaluate stabilized late adverse effects.
Patients who satisfied the inclusion criteria were informed about the study: 30 out of 38 (79%) alive patients accepted to participate. Healthy subjects were patients with vocal fold nodules or polyps and without any disease interfering with taste and smell. All persons gave their informed consent prior to their inclusion in the study. University of Turin Institutional Review Board approval was obtained. The study complies with the Declaration of Helsinki for Medical Research involving Human Subjects.
Basing on radiation techniques, patients were divided in 2 groups: 2-dimensional or conformal 3-dimensional radiotherapy (2D-RT, 5 pts and 3D-CRT, 5 pts) and IMRT (20 pts). Basically, patients who were diagnosed more recently were treated with a newer technique. The groups were homogenous for age, stage, chemotherapy, and radiotherapy doses.
Mean age was 52.35 ± 11.89 years (range 42-76 years) for the control group and 53.53 ± 10.96 years (range 37-75 years) for the treated group. Socio-demographic and clinical characteristics such as age and sex, tobacco, alcohol consumption, previous exposure to irritant substances, gastro-esophageal reflux and allergies are reported in Table 1 . Tumor-related factors, such as histological type, TNM classification, and stage are also given in Table 1 . There were no clinical or demographic differences between control group and treatment group and between patients enrolled and patients who declined participation in the study (P > 0.05).
Chemo-radiotherapy schemes are reported in Table 2 . Cisplatinbased concurrent chemotherapy (CT) was 30 mg/m 2 administrated weekly (range of cycles: 1-3) or 100 mg/m 2 administered once every 3 weeks (range of cycles: 5-8); neoadjuvant CT schemes included cisplatin/fluorouracil or taxanes/cisplatin/fluorouracil (range of cycles: 1-3); lastly adjuvant CT was based on cisplatin and fluorouracil (range of cycles: 1-2). Only 2 patients underwent selective or type III modified radical neck dissection for persistent nodal disease.
All patients were immobilized with a thermoplastic mask. The radiation techniques are described elsewhere (Moretto et al. 2014 ).
In the 2D-RT and 3D-CRT group, nasopharynx and metastatic lymph nodes were treated up to 70.2 Gy (1.8 Gy daily fractions, 5 fractions per week) with a 6 MV LINAC (Elekta SL-75). The uninvolved nodal levels I-IV and retropharyngeal nodes were treated bilaterally with 45-64.8 Gy using a shrinking lateral opposed field technique, with 50-54 Gy to the lower part of the neck and supraclavicular fossae. High-energy electron boost (10-20 Gy) was used for posterior neck lymph nodes.
In IMRT patients, a variety of schedule was used, for example, 69.44 Gy in 32 fractions, 69.96 Gy in 33 fractions, or 70 Gy in 35 fractions to the nasopharynx and involved nodes, 51.2 Gy in 32 fractions, 54.25 Gy in 35 fractions, or 59.4 Gy in 33 fractions to the node-negative regions. Eventually, 60.8 Gy in 32 fractions, 63 Gy in 35 fractions, or 57.6 Gy in 32 fractions were delivered to high-risk negative lymph node echelons. The dose to the lower neck and supraclavicular fossae was 50 Gy in 25 fractions in the split-field technique. IMRT plans were delivered with a 6 MV LINAC (Elekta Precise or Elekta Synergy). A sparing of at least 1 parotid gland was attempted, especially the contralateral 1 with respect to the tumor or metastatic lymph nodes.
All subjects underwent symptoms' anamnestic evaluation (rhinorrhea, nasal obstruction, xerostomy, reduced or altered taste and smell function), oropharyngeal exam, and endoscopic fiber optic nasal examination. Gustatory and olfactory impairments were investigated with taste strips and Sniffin' sticks tests Landis et al. 2009 ).
Taste strips test (Burghart Messtechnik) was based on filter paper strips, impregnated with tastant (4 concentrations each of the 4 basic taste qualities). The following concentrations were used: sweet: 0.4, 0.2, 0.1, 0.05 g/mL sucrose; sour: 0.3, 0.165, 0.09, 0.05 g/mL citric acid; salty: 0.25, 0.1, 0.04, 0.016 g/mL sodium chloride; and bitter: 0.006, 0.0024, 0.0009, 0.0004 g/mL quinine hydrochloride. The strips were placed on the anterior third of the tongue. Before each administration of a strip, the mouth was rinsed with water. The tastes were presented in increasing concentrations and taste qualities were applied in a randomized fashion at each of the 4 levels of concentration. Patients had to identify the taste from a list of 5 descriptors: sweet, sour, salty, bitter, and no taste (multiple forced-choice). To obtain an impression of overall gustatory function, the number of correctly identified tastes was added up to a "taste score." A taste score inferior to 12 is consistent with hypogeusia. Two interposed tasteless strips were used but they were not a component of the final score (Mueller et al. 2007) .
Sniffin' sticks (Burghart Messtechnik) test was based on pen-like odor dispensing devices and consisted of 3 tests of olfactory function, namely tests for odor threshold, odor discrimination, and odor identification (Hummel et al. 1997 . Non-lateralized measures were used in this analysis. Odor thresholds for n-butanol were assessed using a single-staircase of 16 dilutions, starting from a 4% n-butanol solution, with a 3 alternative forced-choice procedure. Three pens were presented in a randomized order, with 2 containing the solvent and the third the odorant. Subjects had to identify the odor-containing pen. Reversal of the staircase was triggered when the odor was correctly identified in 2 successive trials. Threshold was defined as the mean of the last 4 of 7 staircase reversals. In the odor discrimination task, again using a 3 alternative forced-choice procedure, 16 triplets of pens were presented in a randomized order, with 2 containing the same and 1 a different odorant. Subjects had to determine which of 3 pens had the different odor. Odor identification was assessed for 16 common odors. Using a multiple choice task, identification of individual odors was performed from lists of 4 descriptors each. Discrimination and identification results were reported as number of correct answers. Results of the 3 subtests were presented as a composite "TDI score," which was the sum of threshold, and correct answers in discrimination and identification subtests. A Threshold Discrimination Identification (TDI) score inferior to 30 is consistent with hyposmia (Wolfensberger et al. 2000) .
Late salivary toxicity was evaluated by means of Radiation Therapy Oncology Group/European Organisation for Research and Treatment of Cancer (RTOG/EORTC) late radiation morbidity scoring system, which analyzes dryness of mouth and salivary response to stimulation with 5 grades (Cooper et al. 1995) .
All statistical analyses were carried out using Statistical Package for Social Sciences, version 17.0. A descriptive analysis of all data was performed and they were reported as means or percentages and standard deviations. The Kolmogorov-Smirnov test demonstrated a nonGaussian distribution of variables, so non-parametric tests were used. The Kruskal-Wallis test was used to assess differences between groups in the mean of continuous variables. Furthermore, multiple comparison analysis was always performed by adopting Mann-Whitney U-test and chi-square test; the Bonferroni method was used in order to have a stricter criterion on whether to accept an effect as significant. The bivariate correlations procedure with Spearman's correlation coefficient was used to measure linear association between variables. A P value less than 0.05 was considered statistically significant.
Results
Symptoms and endoscopic findings of healthy subjects and treated patients are reported in Table 3 . A higher percentage of rhinorrhea, nasal obstruction, xerostomy, hyposmia, and hypogeusia at anamnestic evaluation and mucosal hyperemia and presence of nasopharyngeal secretions at fiber optic endoscopic examination was found in irradiated subjects (P < 0.05). No differences were observed between different radiation techniques, except for xerostomia (P < 0.05; Table 4 ).
The RTOG/EORTC scale evaluation of the salivary gland functioning in the treated group demonstrated moderate-severe toxicity (grade 2-3) in 67% of the sample and a slight impairment (grade 1) in 23% of patients. Lower moderate-severe salivary dysfunction (55%) was observed in patients who underwent IMRT (P < 0.05). Concerning olfactory threshold, TDI score, bitter, sour and gustatory total score, Sniffin' sticks and taste strips tests demonstrated a statistically significant difference between healthy subjects and irradiated patients (P < 0.05; Table 5 ). Smell and taste results with different radiation techniques are shown in Table 6 . Sweet, bitter, salty, and taste total score was significantly lower for IMRT, compared with 2D-RT/3D-CRT group (P < 0.05).
Analyzing olfactory and gustatory data of the entire sample of irradiated patients, no statistically significant correlations have been found with physical findings (turbinate hypertrophy, nasal and oral mucositis, nasopharyngeal secretions), patients' age, tobacco smoking, gastro-esophageal reflux, and follow-up period (P > 0.05). Furthermore, no significant differences were found between taste total score, xerostomy, and parotid radiation doses (P > 0.05).
Discussion
In the last years, the evaluation of late toxicity in head and neck cancer treatments has assumed an important role for patients' quality of life. Chemo-radiotherapy for NPC can induce long-term effects, such as mucous membrane atrophy and dryness, subcutaneous fibrosis, and dysphagia, which have been confirmed by our study. In literature, some authors reported olfactory and gustatory loss after external beam RT for NPC (Hua et al. 1999; Ho et al. 2002; Ruo Redda and Allis 2006; Baharvand et al. 2013 ).
The aim of our study was a better assessment of smell and taste disorders in patients treated with chemo-RT for NPC. We observed a deterioration of olfactory and gustatory threshold scores, compared with healthy subjects. Moreover, we analyzed the differences in sensorial toxicities between old and new RT techniques, demonstrating greater gustatory dysfunctions in patients treated with IMRT.
Some studies have been conducted on smell and taste disorders in head and neck RT, with particular attention to acute complications (Beidler and Smith 1991; Kamprad et al. 2008; Wismer 2008) . However, late sensorial impairments have not been well investigated, although they are frequently encountered in daily clinical practice. Barbieri et al. (1988) observed that taste loss reached its peak 30 days after head and neck RT and further investigations by Maes and Sandow demonstrated a slow recovery of taste deficits between 6 and 12 months after RT for oropharyngeal cancer (Maes et al. 2002; Sandow et al. 2006) . However, other studies suggested that sometimes a complete recovery was not reached lifelong; Mossman et al. (1982) reported an objective taste loss in 69% of patients at 7-years follow-up, whereas only 15% had subjective taste impairment.
In order to evaluate radiation fields impact on taste loss, Fernando et al. (1995) showed a correlation between objective and subjective gustatory disorders and irradiated tongue volumes. RT determines a disappearance of taste buds, but not a damage to the taste nerves (Zuniga et al. 1993; Yamashita et al. 2006; Mirza et al. 2008) . As forward reported, our results of reduced taste score are in agreement with these findings. Hypogeusia could be a consequence of the disappearance of taste buds. Nevertheless, age, sex, radiotherapy fractions, and dosage have no significant effects on tastes alterations in head and neck cancer (Baharvand et al. 2013) .
Several reports identified diminished threshold sensitivity for at least 1 taste quality; however, the severity and pattern of taste impairments are still in controversy (Ruo Redda and Allis 2006) . Some studies argued that the bitter and the salty qualities showed the earliest and greatest impairment, whereas the sweet quality showed the least (Mossman and Henkin 1978; Mossman et al. 1982; Maes et al. 2002) ; other authors demonstrated higher salty, sweet, and sour taste scores and a lower bitter taste score (Caputo et al. 2012) . In addition to the 4 basic tastes, a significantly impaired threshold of umami taste was revealed (Shi et al. 2004; Yamashita et al. 2009 ).
Furthermore, it is important to consider that chemotherapy may induce sensorial side effects. A broad range of chemotherapy agents, such as 6-mercaptopurine, methotrexate, vincristine, cisplatin, and doxorubicin as well as carboplatin, cyclophosphamide, A P value <0.05 was considered statistically significant. n.s., not significant; TDI, threshold discrimination identification score. A P value <0.05 was considered statistically significant. n.s., not significant; TDI, threshold discrimination identification score.
and 5-fluorouracil, can be associated with taste disorders. Taste and smell alterations are generally transient after CT (Fischer and Epstein 2008) . However, studies providing comparisons between CT agents and their impact on taste and smell are rare (Wickham et al. 1999; Bernhardson et al. 2008; Steinbach et al. 2009; Zabernigg et al. 2010; Gamper et al. 2012) . Nevertheless, no statistically significant differences regarding taste perception were observed in RT for head and neck cancer with or without chemotherapy (Yamashita et al. 2006) . Lastly, gustatory alterations may be due to olfactory changes (Bhattacharyya and Kepnes 2014) . These findings are important in order to correctly evaluate the effects of chemo-radiotherapy in this study. Concerning smell and taste changes in NPC, a few studies are present in literature; moreover, they only investigated relationship between smell dysfunctions and RT. Generally, the NPC patients who underwent RT manifested impairments in absolute olfactory threshold sensitivity, verbal identification of odors, recall, and recognition of odor identity. In terms of neuroanatomical correlations, the deficit of absolute olfactory threshold suggested a dysfunction of both central and peripheral olfactory neural substrates. The impairments of suprathreshold olfactory functioning seemed to reflect a dysfunction of the orbitofrontal cortex and the mesial temporal structures including the temporal prepiriform cortex (Hua et al. 1999) . Ho et al. (2002) found that mean olfactory threshold scores by the Sniffin' sticks test deteriorate significantly at 12 months when compared with the scores before irradiation. However, olfactory discrimination and identification did not exhibit any significant changes when assessed at 12 months. This suggested that suprathreshold functioning is not altered as it involves higher brain centers, which are spared from radiation delivered to the nasopharynx, except for the hypothalamus which is partly irradiated (Ho et al. 2002) . As demonstrated by Ho et al., we found a greatest alteration in olfactory threshold score, compared with odor discrimination and identification.
According to literature, this study showed a deterioration of olfactory and gustatory threshold scores. Concerning taste disorders, we observed an alteration of all taste qualities, with lower scores for bitter and sour ones. Salty and sweet scores were just below normal levels. Adaptation to sensorial impairment can explain the discrepancy between subjective symptoms (hyposmia 30% and hypogeusia 53%) and objective measurements (smell disorders with TDI score < 30: 86%; taste disorders with total score < 12: 81%).
Unlike healthy subjects (Kaneda et al. 2000; Ng et al. 2004; Hummel et al. 2007; Boesveldt et al. 2011) , in this study, there was no correlation between sensorial disturbs and patients' age. These data suggest a common effect of radiotherapy on smell and taste, independent of patients' age; however, larger samples are needed to confirm the results. The absence of correlation between clinical findings (inferior turbinate hypertrophy, erythema of the nasal mucosa, nasal mucous secretions) and olfactory impairment suggests that threshold score alterations may be due to a sensorineural deficit of olfactory mucosa or nerve fibers, rather than conductive problems, according to the results reported by Ho et al. (2002) . Similarly, no correlation between clinical findings (erythema of the oral mucosa), late salivary toxicity (dryness of mouth and thickened saliva), and taste deterioration was seen, according to the literature findings (Mossman et al. 1982; Zheng et al. 2002; Yamashita et al. 2006; Mirza et al. 2008) , although saliva was considered the solvent for gustatory stimuli.
In order to reduce injuries to healthy tissues, which is the mean factor limiting radiation doses, over the past decade the advances of modern RT techniques for treating NPC have emerged with the development of IMRT. It allows a good disease control (Moretto et al. 2014) , with lower doses to normal tissues and critical structures, such as brain stem, spinal cord, parotid glands, and temporomandibular joints, with less late salivary toxicity (Fang et al. 2008) . Our results confirmed the parotid sparing and lower salivary toxicity of IMRT, compared with 2D-RT and 3D-CRT techniques.
In our knowledge, this is the first study that evaluated differences in olfactory and gustatory alterations between old and new RT techniques. Greater gustatory dysfunctions were observed in patients treated with IMRT; it can be explained by the higher doses to anterior oral cavity in IMRT. In older techniques, part of the oral cavity was shielded by appropriate tools.
In conclusion, chemo-radiotherapy for NPC induces long-term toxicities, which can compromise quality of life. Taste impairments, coupled with xerostomia and dysphagia, reduce food enjoyment and affect the nutritional status of the patients. Therefore, it is important to inform the patients that RT may induce xerostomia, smell and taste disorders. Further prospective studies regarding new RT techniques, evaluating radiation doses on oral cavity, are necessary to plan better radiation fields in order to reduce late toxicities. Moreover, correlation with histological studies may be helpful to show the degrees of mucosal damage.
